guest ::
| Home > Publications Database > Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. > print |
| Home > Publications Database > Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. > print |
| 001 | 138892 | ||
| 005 | 20240321220522.0 | ||
| 024 | 7 | _ | |a 10.1002/ana.24781 |2 doi |
| 024 | 7 | _ | |a pmid:27717005 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC5244667 |2 pmc |
| 024 | 7 | _ | |a 0364-5134 |2 ISSN |
| 024 | 7 | _ | |a 1531-8249 |2 ISSN |
| 024 | 7 | _ | |a altmetric:12138885 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-05214 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Liu, Ganqiang |b 0 |
| 245 | _ | _ | |a Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. |
| 260 | _ | _ | |a Hoboken, NJ |c 2016 |b Wiley-Blackwell |
| 264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2016-11-18 |
| 264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2016-11-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1586181625_18620 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a We hypothesized that specific mutations in the β-glucocerebrosidase gene (GBA) causing neuropathic Gaucher's disease (GD) in homozygotes lead to aggressive cognitive decline in heterozygous Parkinson's disease (PD) patients, whereas non-neuropathic GD mutations confer intermediate progression rates.A total of 2,304 patients with PD and 20,868 longitudinal visits for up to 12.8 years (median, 4.1) from seven cohorts were analyzed. Differential effects of four types of genetic variation in GBA on longitudinal cognitive decline were evaluated using mixed random and fixed effects and Cox proportional hazards models.Overall, 10.3% of patients with PD and GBA sequencing carried a mutation. Carriers of neuropathic GD mutations (1.4% of patients) had hazard ratios (HRs) for global cognitive impairment of 3.17 (95% confidence interval [CI], 1.60-6.25) and a hastened decline in Mini-Mental State Exam scores compared to noncarriers (p = 0.0009). Carriers of complex GBA alleles (0.7%) had an HR of 3.22 (95% CI, 1.18-8.73; p = 0.022). By contrast, the common, non-neuropathic N370S mutation (1.5% of patients; HR, 1.96; 95% CI, 0.92-4.18) or nonpathogenic risk variants (6.6% of patients; HR, 1.36; 95% CI, 0.89-2.05) did not reach significance.Mutations in the GBA gene pathogenic for neuropathic GD and complex alleles shift longitudinal cognitive decline in PD into 'high gear.' These findings suggest a relationship between specific types of GBA mutations and aggressive cognitive decline and have direct implications for improving the design of clinical trials. Ann Neurol 2016;80:674-685. |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-09-01 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Glucosylceramidase |0 EC 3.2.1.45 |2 NLM Chemicals |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: etiology |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction: genetics |2 MeSH |
| 650 | _ | 2 | |a Disease Progression |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Gaucher Disease: complications |2 MeSH |
| 650 | _ | 2 | |a Gaucher Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Glucosylceramidase: genetics |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Longitudinal Studies |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: complications |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: genetics |2 MeSH |
| 700 | 1 | _ | |a Boot, Brendon |b 1 |
| 700 | 1 | _ | |a Locascio, Joseph J |b 2 |
| 700 | 1 | _ | |a Jansen, Iris E |0 P:(DE-2719)2813349 |b 3 |u dzne |
| 700 | 1 | _ | |a Winder-Rhodes, Sophie |b 4 |
| 700 | 1 | _ | |a Eberly, Shirley |b 5 |
| 700 | 1 | _ | |a Elbaz, Alexis |b 6 |
| 700 | 1 | _ | |a Brice, Alexis |b 7 |
| 700 | 1 | _ | |a Ravina, Bernard |b 8 |
| 700 | 1 | _ | |a van Hilten, Jacobus J |b 9 |
| 700 | 1 | _ | |a Cormier-Dequaire, Florence |b 10 |
| 700 | 1 | _ | |a Corvol, Jean-Christophe |b 11 |
| 700 | 1 | _ | |a Barker, Roger A |b 12 |
| 700 | 1 | _ | |a Heutink, Peter |0 P:(DE-2719)2810728 |b 13 |u dzne |
| 700 | 1 | _ | |a Marinus, Johan |b 14 |
| 700 | 1 | _ | |a Williams-Gray, Caroline H |b 15 |
| 700 | 1 | _ | |a Scherzer, Clemens R |0 P:(DE-HGF)0 |b 16 |e Corresponding author |
| 700 | 1 | _ | |a Progression, International Genetics of Parkinson Disease |b 17 |
| 700 | 1 | _ | |a Scherzer, C. |b 18 |
| 700 | 1 | _ | |a Hyman, B. T. |b 19 |
| 700 | 1 | _ | |a Ivinson, A. J. |b 20 |
| 700 | 1 | _ | |a Trisini-Lipsanopoulos, A. |b 21 |
| 700 | 1 | _ | |a Franco, D. |b 22 |
| 700 | 1 | _ | |a Burke, K. |b 23 |
| 700 | 1 | _ | |a Sudarsky, L. R. |b 24 |
| 700 | 1 | _ | |a Hayes, M. T. |b 25 |
| 700 | 1 | _ | |a Umeh, C. C. |b 26 |
| 700 | 1 | _ | |a Growdon, J. H. |b 27 |
| 700 | 1 | _ | |a Schwarzschild, M. A. |b 28 |
| 700 | 1 | _ | |a Hung, A. Y. |b 29 |
| 700 | 1 | _ | |a Flaherty, A. W. |b 30 |
| 700 | 1 | _ | |a Wills, A-M |b 31 |
| 700 | 1 | _ | |a Mejia, N. I. |b 32 |
| 700 | 1 | _ | |a Gomperts, S. N. |b 33 |
| 700 | 1 | _ | |a Khurana, V. |b 34 |
| 700 | 1 | _ | |a Selkoe, D. J. |b 35 |
| 700 | 1 | _ | |a Yi, T. |b 36 |
| 700 | 1 | _ | |a Page, K. |b 37 |
| 700 | 1 | _ | |a Liao, Z. |b 38 |
| 700 | 1 | _ | |a Barker, R. |b 39 |
| 700 | 1 | _ | |a Foltynie, T. |b 40 |
| 700 | 1 | _ | |a Williams-Gray, C. H. |b 41 |
| 700 | 1 | _ | |a Mason, S. |b 42 |
| 700 | 1 | _ | |a Winder-Rhodes, S. |b 43 |
| 700 | 1 | _ | |a Barker, R. |b 44 |
| 700 | 1 | _ | |a Williams-Gray, C. H. |b 45 |
| 700 | 1 | _ | |a Breen, D. |b 46 |
| 700 | 1 | _ | |a Cummins, G. |b 47 |
| 700 | 1 | _ | |a Evans, J. |b 48 |
| 700 | 1 | _ | |a Winder-Rhodes, S. |b 49 |
| 700 | 1 | _ | |a Corvol, J-C |b 50 |
| 700 | 1 | _ | |a Brice, A. |b 51 |
| 700 | 1 | _ | |a Elbaz, A. |b 52 |
| 700 | 1 | _ | |a Mallet, A. |b 53 |
| 700 | 1 | _ | |a Vidailhet, M. |b 54 |
| 700 | 1 | _ | |a Bonnet, A-M |b 55 |
| 700 | 1 | _ | |a Bonnet, C. |b 56 |
| 700 | 1 | _ | |a Grabli, D. |b 57 |
| 700 | 1 | _ | |a Hartmann, A. |0 P:(DE-HGF)0 |b 58 |
| 700 | 1 | _ | |a Klebe, S. |b 59 |
| 700 | 1 | _ | |a Lacomblez, L. |b 60 |
| 700 | 1 | _ | |a Mangone, G. |b 61 |
| 700 | 1 | _ | |a Bourdain, F. |b 62 |
| 700 | 1 | _ | |a Brandel, J-P |b 63 |
| 700 | 1 | _ | |a Derkinderen, P. |b 64 |
| 700 | 1 | _ | |a Durif, F. |b 65 |
| 700 | 1 | _ | |a Mesnage, V. |b 66 |
| 700 | 1 | _ | |a Pico, F. |b 67 |
| 700 | 1 | _ | |a Rascol, O. |b 68 |
| 700 | 1 | _ | |a Forlani, S. |b 69 |
| 700 | 1 | _ | |a Lesage, S. |b 70 |
| 700 | 1 | _ | |a Tahiri, K. |b 71 |
| 700 | 1 | _ | |a van Hilten, J. J. |b 72 |
| 700 | 1 | _ | |a Marinus, J. |b 73 |
| 700 | 1 | _ | |a Liao, Z. |b 74 |
| 700 | 1 | _ | |a Page, K. |b 75 |
| 700 | 1 | _ | |a Franco, D. |b 76 |
| 700 | 1 | _ | |a Duong, K. |b 77 |
| 700 | 1 | _ | |a Yi, T. |b 78 |
| 700 | 1 | _ | |a Trisini-Lipsanopoulos, A. |b 79 |
| 700 | 1 | _ | |a Dong, X. |b 80 |
| 700 | 1 | _ | |a Sudarsky, L. R. |b 81 |
| 700 | 1 | _ | |a Hutten, S. J. |b 82 |
| 700 | 1 | _ | |a Amr, S. S. |b 83 |
| 700 | 1 | _ | |a Shoulson, I. |b 84 |
| 700 | 1 | _ | |a Tanner, C. M. |b 85 |
| 700 | 1 | _ | |a Lang, A. E. |0 P:(DE-HGF)0 |b 86 |
| 700 | 1 | _ | |a Nalls, M. A. |b 87 |
| 773 | 1 | 8 | |a 10.1002/ana.24781 |b : Wiley, 2016-11-01 |n 5 |p 674-685 |3 journal-article |2 Crossref |t Annals of Neurology |v 80 |y 2016 |x 0364-5134 |
| 773 | _ | _ | |a 10.1002/ana.24781 |g Vol. 80, no. 5, p. 674 - 685 |0 PERI:(DE-600)2037912-2 |n 5 |q 80:5<674 - 685 |p 674-685 |t Annals of neurology |v 80 |y 2016 |x 0364-5134 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244667 |
| 909 | C | O | |o oai:pub.dzne.de:138892 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2813349 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2810728 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 0 |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANN NEUROL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ANN NEUROL : 2017 |
| 920 | 1 | _ | |0 I:(DE-2719)1210002 |k AG Heutink 1 |l Genome Biology of Neurodegenerative Diseases |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1210002 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1136/jnnp.69.3.308 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jnnp.69.3.308 |
| 999 | C | 5 | |a 10.1002/humu.20676 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.20676 |
| 999 | C | 5 | |a 10.1002/ajh.24063 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ajh.24063 |
| 999 | C | 5 | |a 10.1056/NEJMoa0901281 |9 -- missing cx lookup -- |2 Crossref |o 10.1056/NEJMoa0901281 |
| 999 | C | 5 | |a 10.1093/brain/awu002 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awu002 |
| 999 | C | 5 | |a 10.1093/brain/aws318 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/aws318 |
| 999 | C | 5 | |a 10.1002/mds.26071 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26071 |
| 999 | C | 5 | |a 10.1016/j.neurobiolaging.2015.09.014 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neurobiolaging.2015.09.014 |
| 999 | C | 5 | |a 10.1016/j.neurobiolaging.2015.08.027 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neurobiolaging.2015.08.027 |
| 999 | C | 5 | |a 10.1093/brain/awv202 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awv202 |
| 999 | C | 5 | |a 10.1136/jnnp-2013-305277 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jnnp-2013-305277 |
| 999 | C | 5 | |a 10.1136/jnnp.2003.017509 |9 -- missing cx lookup -- |2 Crossref |o 10.1136/jnnp.2003.017509 |
| 999 | C | 5 | |a 10.1002/mds.22690 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.22690 |
| 999 | C | 5 | |a 10.1007/s00415-013-6905-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00415-013-6905-3 |
| 999 | C | 5 | |a 10.1212/WNL.40.10.1529 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.40.10.1529 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000266593.50534.e8 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000266593.50534.e8 |
| 999 | C | 5 | |a 10.1093/brain/awh067 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awh067 |
| 999 | C | 5 | |a 10.1001/jamaneurol.2014.65 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/jamaneurol.2014.65 |
| 999 | C | 5 | |a 10.1002/mds.23934 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.23934 |
| 999 | C | 5 | |a 10.1016/j.nbd.2009.02.016 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.nbd.2009.02.016 |
| 999 | C | 5 | |a 10.1002/ana.22687 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.22687 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3182a95818 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0b013e3182a95818 |
| 999 | C | 5 | |a 10.1001/archneur.1989.00520460028009 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/archneur.1989.00520460028009 |
| 999 | C | 5 | |a 10.1093/brain/awp245 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awp245 |
| 999 | C | 5 | |a 10.1038/ng.3043 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ng.3043 |
| 999 | C | 5 | |a 10.1093/brain/awf080 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awf080 |
| 999 | C | 5 | |a 10.1093/bioinformatics/btp324 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/bioinformatics/btp324 |
| 999 | C | 5 | |a 10.1101/gr.107524.110 |9 -- missing cx lookup -- |2 Crossref |o 10.1101/gr.107524.110 |
| 999 | C | 5 | |a 10.1093/hmg/ddq454 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/hmg/ddq454 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000327823.81237.d1 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000327823.81237.d1 |
| 999 | C | 5 | |a 10.1016/j.ymgme.2011.12.002 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ymgme.2011.12.002 |
| 999 | C | 5 | |a 10.1159/000330228 |9 -- missing cx lookup -- |2 Crossref |o 10.1159/000330228 |
| 999 | C | 5 | |y 2014 |2 Crossref |t R: A language and environment for statistical computing |o Team RDC R: A language and environment for statistical computing 2014 |
| 999 | C | 5 | |a 10.1002/mds.21844 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.21844 |
| 999 | C | 5 | |y 2002 |2 Crossref |t Missing Data-Quantitative Applications in the Social Sciences |o Allison Missing Data-Quantitative Applications in the Social Sciences 2002 |
| 999 | C | 5 | |a 10.1002/mds.20213 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.20213 |
| 999 | C | 5 | |a 10.1093/brain/awv179 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awv179 |
| 999 | C | 5 | |a 10.1371/journal.pone.0036199 |9 -- missing cx lookup -- |2 Crossref |o 10.1371/journal.pone.0036199 |
| 999 | C | 5 | |a 10.1212/01.wnl.0000304039.11891.29 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/01.wnl.0000304039.11891.29 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000001315 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0000000000001315 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3181c34b47 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0b013e3181c34b47 |
| 999 | C | 5 | |y 2005 |2 Crossref |o Gilks 2005 |
| 999 | C | 5 | |a 10.1002/ana.24664 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24664 |
| 999 | C | 5 | |a 10.1016/j.parkreldis.2014.06.006 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.parkreldis.2014.06.006 |
| 999 | C | 5 | |a 10.1002/ana.23614 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.23614 |
| 999 | C | 5 | |a 10.1038/ejhg.2013.182 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ejhg.2013.182 |
| 999 | C | 5 | |a 10.1002/ana.22400 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.22400 |
| 999 | C | 5 | |a 10.1038/ncomms5028 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ncomms5028 |
| 999 | C | 5 | |a 10.1016/j.cell.2011.06.001 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.cell.2011.06.001 |
| 999 | C | 5 | |a 10.1073/pnas.1108197108 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.1108197108 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|